Clinical Trials Directory

Trials / Completed

CompletedNCT02353910

VTE Incidence in Severe Sepsis and Septic Shock

VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock

Status
Completed
Phase
Study type
Observational
Enrollment
113 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

Prospective studies on the incidence of VTE during severe sepsis and septic shock remain absent, hindering efficacy assessments regarding current VTE prevention strategies in septic patients. The investigators will prospectively study consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients will provide informed consent and the study will be IRB approved. VTE thromboprophylaxis, provided per standard of care and according to the patients' primary team, will be recorded for all patients. Patients will undergo bilateral lower (and upper, if a central venous catheter \[CVC\] was present) comprehensive compression ultrasonography (CUS) and will be followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. The investigators will perform multivariate regression analyses to identify predictors of VTE.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound

Timeline

Start date
2009-07-01
Primary completion
2014-12-01
First posted
2015-02-03
Last updated
2015-02-03

Source: ClinicalTrials.gov record NCT02353910. Inclusion in this directory is not an endorsement.